Madame Amira GABSI / Docteur

Production scientifique

• [Is there a place of multiantigenes immunodot determination in systemic sclerosis patients without anti-centromeres or anti-Scl70 antibodies?].
  PRESS MED, 2015
  Sautereau N, Gabsi A, Daumas A, Bardin N, Granel B
  http://www.ncbi.nlm.nih.gov/pubmed/25813097
  
• CD146 et CD146s : NOUVELLE CIBLE DE LA SCLERODERMIE SYSTEMIQUE
  société tunisienne d'immunologie, 2014
  GABSI A, KAPSI E, TRIKI MARRAKCHI R, BEN AMMAR ELGAEID A, BARDIN N, DIGNAT-GEORGE F
  
  
• Scleroderma, between CD146 and the WNT signaling pathway
  FAIS AFRICA cours nord africain d'immunologie, 2016
  GABSI.A KAPSI.E MARRAKCHI TRIKI.R BARDIN.N
  
  
• TH17 expressing CD146 cells are significantly increased in patients with Systemic sclerosis
  scientific reports, 2019
  Gabsi Amira1,2* , Xavier Heim2,5 , Dlala Akram1 ,Sakhri Haifa1,Amri Sonia1, Neili Bilel 1, Abidi Ahmed1 , Asma Gati1 , Aurelie S Leroyer2 , Alexandrine Bertaud2, Smiti Khanfir Monia3,4 , Said Fatma3,4 , Houman Mohamed Habib3,4, Brigitte Granel6, Marcel Blot Chabaud2, Bardin Nathalie2,5*, Marrakchi Raja1* *Equal contribution
  
  
• Th17 and Regulatory T cells axis in a Tunisian population of systemic sclerosis Disease
  Human immunology, 2019
  Gabsi Amira1,2 , Dlala Akrem1 , Sakhri Haifa1, Khalil Ben salem1, Abidi Ahmed1, Neili Bilel1 , Amri Sonia1, Asma Gati1, Smiti Khanfir Monia3,4 , Said Fatma3,4 , Houman Mohamed Habib3,4, Bardin Nathalie25, Marrakchi Raja1